These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study. Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278 [TBL] [Abstract][Full Text] [Related]
23. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation. Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ mBio; 2016 Dec; 7(6):. PubMed ID: 27999162 [TBL] [Abstract][Full Text] [Related]
24. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107 [TBL] [Abstract][Full Text] [Related]
25. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. Cammarota G; Ianiro G; Gasbarrini A J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934 [TBL] [Abstract][Full Text] [Related]
26. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
27. Fecal microbiota transplantation for recurrent Clostridioides difficile infection. Haber SL; Raney CRK; Larson TL; Lau JP Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890 [TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital. Mironova M; Ehrlich AC; Grinspan A; Protano MA J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340 [TBL] [Abstract][Full Text] [Related]
29. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement. Chauhan A; Apostolov R; van Langenberg D; Garg M Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016 [TBL] [Abstract][Full Text] [Related]
30. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature. Lin SC; Alonso CD; Moss AC Transpl Infect Dis; 2018 Dec; 20(6):e12967. PubMed ID: 30011107 [TBL] [Abstract][Full Text] [Related]
31. Faecal microbiota transplantation for treatment of recurrent or refractory Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437 [TBL] [Abstract][Full Text] [Related]
32. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805 [TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. Hui W; Li T; Liu W; Zhou C; Gao F PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716 [TBL] [Abstract][Full Text] [Related]
34. Five years of fecal microbiota transplantation - an update of the Israeli experience. Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis. Pomares Bascuñana RÁ; Veses V; Sheth CC Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273 [TBL] [Abstract][Full Text] [Related]
36. [Customised infectiology - Fecal microbiota transplantation : following the Galperine TK; Guery B Rev Med Suisse; 2019 Apr; 15(646):776-779. PubMed ID: 30969490 [TBL] [Abstract][Full Text] [Related]
37. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ; United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950 [TBL] [Abstract][Full Text] [Related]
38. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Hosts. Revolinski S; Munoz-Price LS Clin Infect Dis; 2021 Jun; 72(12):2247. PubMed ID: 32275059 [No Abstract] [Full Text] [Related]
39. Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases. Oprita R; Bratu M; Oprita B; Diaconescu B J Med Life; 2016; 9(2):160-2. PubMed ID: 27453747 [TBL] [Abstract][Full Text] [Related]